Vanguard Group’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$139M Buy
15,555,606
+101,011
+0.7% +$626K ﹤0.01% 1719
2025
Q3
$57.2M Sell
15,454,595
-448,459
-3% -$1.22M ﹤0.01% 2091
2025
Q2
$31M Buy
15,903,054
+505,234
+3% +$1.05M ﹤0.01% 2348
2025
Q1
$27.1M Sell
15,397,820
-334,747
-2% -$762K ﹤0.01% 2363
2024
Q4
$41.8M Buy
15,732,567
+4,913,820
+45% +$12.7M ﹤0.01% 2239
2024
Q3
$24.8M Buy
10,818,747
+675,849
+7% +$2.06M ﹤0.01% 2486
2024
Q2
$29.6M Buy
10,142,898
+2,608,750
+35% +$7.96M ﹤0.01% 2370
2024
Q1
$27.4M Buy
7,534,148
+219,533
+3% +$422K ﹤0.01% 2441
2023
Q4
$11M Buy
7,314,615
+18,457
+0.3% +$23.8K ﹤0.01% 2891
2023
Q3
$9.78M Buy
7,296,158
+17,118
+0.2% +$28.5K ﹤0.01% 2896
2023
Q2
$13.1M Buy
7,279,040
+76,574
+1% +$130K ﹤0.01% 2797
2023
Q1
$12M Sell
7,202,466
-2,729,975
-27% -$5.53M ﹤0.01% 2845
2022
Q4
$19.1M Sell
9,932,441
-2,712,010
-21% -$5.49M ﹤0.01% 2650
2022
Q3
$28.3M Buy
12,644,451
+11,813
+0.1% +$33.7K ﹤0.01% 2471
2022
Q2
$40.9M Sell
12,632,638
-299,822
-2% -$1.31M ﹤0.01% 2290
2022
Q1
$68M Buy
12,932,460
+1,671,908
+15% +$9.39M ﹤0.01% 2144
2021
Q4
$95.7M Sell
11,260,552
-641,975
-5% -$5.9M ﹤0.01% 2007
2021
Q3
$118M Buy
11,902,527
+806,166
+7% +$7.31M ﹤0.01% 1901
2021
Q2
$103M Buy
11,096,361
+4,139,205
+59% +$47.2M ﹤0.01% 1984
2021
Q1
$72.7M Buy
+6,957,156
New +$77.8M ﹤0.01% 2116

Other funds holding NUVB